Express Scripts Hopes To Refine Risk Level Under Medicare Rx
This article was originally published in The Pink Sheet Daily
Express Scripts is hopeful that the Medicare Rx implementing regs can be refined to have a manageable level of risk, CEO Barrett Toan told analysts July 29
You may also be interested in...
Medco has been asked by CMS to offer constructive ideas to help make private drug insurance work, and company says it intends to do that in commenting on Part D regulations. However, CEO suggests Medco remains most interested in working under Medicare Advantage and through "fallback" plan.
Proposed rules for Title I (Part D drug benefit) and Title II (Medicare Advantage) of the Medicare Modernization Act are unveiled at an HHS press conference. Final regs will be done by early 2005, "if not sooner," CMS Administrator McClellan says.
The U.S. Global AIDS Coordinator's Office suggests it will use its authority to purchase an FDA-approved generic antiretroviral product for which permission could not be obtained from the patent holder. FDA grants tentative approval to a South African firm for a generic co-packaged version of Combivir and Viramune.